Profit Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-215,559
Closed -$2.36M 96
2017
Q2
$2.36M Sell
215,559
-21,658
-9% -$237K 2.13% 9
2017
Q1
$2.5M Buy
237,217
+148,440
+167% +$1.44M 2.03% 12
2016
Q4
$746K Hold
88,777
0.71% 65
2016
Q3
$636K Hold
88,777
0.63% 67
2016
Q2
$683K Hold
88,777
0.55% 70
2016
Q1
$649K Buy
88,777
+48,985
+123% +$351K 0.28% 76
2015
Q4
$307K Sell
39,792
-26,852
-40% -$205K 0.1% 96
2015
Q3
$477K Sell
66,644
-16,333
-20% -$157K 0.07% 111
2015
Q2
$881K Sell
82,977
-14,215
-15% -$166K 0.1% 102
2015
Q1
$1.2M Hold
97,192
0.06% 115
2014
Q4
$907K Sell
97,192
-7,422
-7% -$71.6K 0.05% 125
2014
Q3
$1.05M Sell
104,614
-18,930
-15% -$193K 0.05% 118
2014
Q2
$1.27M Sell
123,544
-115,379
-48% -$1.25M 0.06% 114
2014
Q1
$2.98M Hold
238,923
0.13% 99
2013
Q4
$2.94M Hold
238,923
0.13% 101
2013
Q3
$2.06K Sell
238,923
-13,383
-5% -$116K 0.08% 110
2013
Q2
$2.19M Buy
+252,306
New +$2.26M 0.11% 110

Other funds holding ELOS

Profit Investment Management's ELOS Position: Q3 2017 in Review

Profit Investment Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 215,559 shares — an estimated $2.36M sold.

Profit Investment Management first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $2.98M in Q1 2014. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Profit Investment Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Profit Investment Management sold 215,559 Syneron Medical Ltd shares in Q3 2017, an estimated $2.36M.
  • Profit Investment Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Profit Investment Management's Syneron Medical Ltd position peaked at $2.98M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Profit Investment Management's 13F filing for Q3 2017, filed 18 Oct 2017.